From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Open accessThe DOI matches its Crossref record; 290 of the 290 references it cites were found in a registry or an index.
Abstract
The lymphatic system serves an integral role in fluid homeostasis, lipid metabolism and immune control. In cancer, the lymph nodes that drain solid tumours are a primary site of metastasis, and recent studies have suggested intrinsic links between lymphatic function, lipid deposition, obesity and atherosclerosis. Advances in the current understanding of the role of the lymphatics in pathological change and immunity have driven the recognition that lymph-targeted delivery has the potential to transform disease treatment and vaccination. In addition, the design of lymphatic delivery systems has progressed from simple systems that rely on passive lymphatic access to sophisticated structures that use nanotechnology to mimic endogenous macromolecules and lipid conjugates that 'hitchhike' onto lipid transport processes. Here, we briefly summarize the lymphatic system in health and disease and the varying mechanisms of lymphatic entry and transport, as well as discussing examples of lymphatic delivery that have enhanced therapeutic utility. We also outline future challenges to effective lymph-directed therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The lymphatic route also exposes lymph-resident tissues, including the mesenteric lymph nodes and circulating lymphocytes, to drug concentrations far higher than those measured in systemic plasma, a property now exploited deliberately for lymph-targeted therapy but also a source of disconnect between plasma-based scaling and tissue exposure [32].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Sleep Drives Metabolite Clearance from the Adult Brain
Xie, L., Kang, H., Xu, Q., Chen, M. J., Liao, Y., Thiyagarajan, M., O’Donnell, J., Christensen, D. J., Nicholson, C., Iliff, J. J., et al. (2013) · Science · doi:10.1126/science.1241224 · Cited by 5,411
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
Aspelund, A., Antila, S., Proulx, S. T., Karlsen, T. V., Karaman, S., Detmar, M., Wiig, H., & Alitalo, K. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142290 · Cited by 2,198
On the Absorption of Fluids from the Connective Tissue Spaces
Starling, E. H. (1896) · The Journal of Physiology · doi:10.1113/jphysiol.1896.sp000596 · Cited by 2,148
CX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611
LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan
Banerji, S., Ni, J., Wang, S.-X., Clasper, S., Su, J., Tammi, R., Jones, M., & Jackson, D. G. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.4.789 · Cited by 1,583
Cited by
Items 101–200 of 653
Structured edible lipid-based particle systems for oral drug-delivery
Ashkar, A., Sosnik, A., & Davidovich‐Pinhas, M. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107789 · Cited by 82
Franco, V., Gershkovich, P., Perucca, E., & Bialer, M. (2020) · Clinical Pharmacokinetics · doi:10.1007/s40262-020-00931-w · Cited by 88
Noninvasive Magnetic Resonance Imaging Measures of Glymphatic System Activity
Kamagata, K., Saito, Y., Andica, C., Uchida, W., Takabayashi, K., Yoshida, S., Hagiwara, A., Fujita, S., Nakaya, M., Akashi, T., et al. (2023) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28977 · Cited by 83
Collins, D. S., Kourtis, L. C., Thyagarajapuram, N. R., Sirkar, R., Kapur, S., Harrison, M. W., Bryan, D. J., Jones, G. B., & Wright, J. M. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2229-9 · Cited by 77
Adityan, S., Tran, M. A., Bhavsar, C., & Wu, S. Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.016 · Cited by 76
Enhancing therapeutic performance of personalized cancer vaccine via delivery vectors
Ye, T., Li, F., Ma, G., & Wei, W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113927 · Cited by 76
Hu, L., Quach, T., Han, S., Lim, S. F., Yadav, P., Senyschyn, D., Trevaskis, N. L., Simpson, J. S., & Porter, C. J. H. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201604207 · Cited by 73
Self-citationOral lipid nanomedicines: Current status and future perspectives in cancer treatment
El Moukhtari, S. H., Rodríguez-Nogales, C., & Blanco-Prieto, M. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.004 · Cited by 70
Hiradate, R., Khalil, I. A., Matsuda, A., Sasaki, M., Hida, K., & Harashima, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.002 · Cited by 74
Regulation of VEGFR Signalling in Lymphatic Vascular Development and Disease: An Update
Secker, G. A., & Harvey, N. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147760 · Cited by 78
Nanoencapsulation of nutraceuticals: enhancing stability and bioavailability in functional foods
Hao, M., Tan, X., Liu, K., & Xin, N. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1746176 · Cited by 104
Peptide Amphiphile Micelle Vaccine Size and Charge Influence the Host Antibody Response
Zhang, R., Smith, J. D., Allen, B. N., Kramer, J. S., Schauflinger, M., & Ulery, B. D. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00511 · Cited by 70
Kappel, C., Seidl, C. I., Medina‐Montano, C., Schinnerer, M., Alberg, I., Leps, C., Sohl, J., Hartmann, A., Fichter, M., Kuske, M., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c05713 · Cited by 74
Subcutaneous drug delivery: An evolving enterprise
Jones, G. B., Collins, D. S., Harrison, M. W., Thyagarajapuram, N. R., & Wright, J. M. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9166 · Cited by 76
Therapeutic Delivery to the Brain via the Lymphatic Vasculature
Zhao, P., Le, Z., Liu, L., & Chen, Y. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c01806 · Cited by 70
Dai, Y., Yu, X. M., Wei, J., Zeng, F., Li, Y., Yang, X., Luo, Q., & Zhang, Z. (2020) · Light Science & Applications · doi:10.1038/s41377-020-00399-0 · Cited by 69
Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery
Huang, L., Jianmiao, Y., Wang, T., Gao, J., & Xu, D. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01257-4 · Cited by 70
Recent advances in long-acting nanoformulations for delivery of antiretroviral drugs
Surve, D. H., & Jindal, A. B. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.022 · Cited by 71
Mao, Y., Feng, S., Li, S., Zhao, Q., Di, D., Liu, Y., & Wang, S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.012 · Cited by 74
Lipid-Based Nanosystem As Intelligent Carriers for Versatile Drug Delivery Applications
Harshita, Barkat, M. A., Das, S. S., Pottoo, F. H., Beg, S., & Rahman, Z. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200206094529 · Cited by 71
Engineering nanoparticulate vaccines for enhancing antigen cross-presentation
Du, G., & Sun, X. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.06.015 · Cited by 69
Unnisa, A., Chettupalli, A. K., Hagbani, T. A., Khalid, M., Jandrajupalli, S. B., Chandolu, S., & Hussain, T. (2022) · Pharmaceuticals · doi:10.3390/ph15050568 · Cited by 73
Li, W., Wu, J., Wu, L., Zhang, B., Hu, H., Zhao, L., Li, Z., Yu, X., & Li, Y. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120788 · Cited by 67
In situ cellular hitchhiking of nanoparticles for drug delivery
Udofa, E., & Zhao, Z. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115143 · Cited by 72
Berrocoso, E., Rey-Brea, R., Arévalo, M. F., Micó, J. A., & Martín‐Banderas, L. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.07.010 · Cited by 68
Mineral oil in food, cosmetic products, and in products regulated by other legislations
Pirow, R., Blume, A., Hellwig, N., Herzler, M., Huhse, B., Hutzler, C., Pfaff, K., Thierse, H., Tralau, T., Vieth, B., et al. (2019) · Critical Reviews in Toxicology · doi:10.1080/10408444.2019.1694862 · Cited by 72
Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines
An, M., & Liu, H. (2017) · Small · doi:10.1002/smll.201700164 · Cited by 66
Wang, F., Ullah, A., Fan, X., Xu, Z., Zong, R., Wang, X., & Chen, G. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.027 · Cited by 70
Characterization and impact of peptide physicochemical properties on oral and subcutaneous delivery
Klepach, A., Tran, H., Mohammed, F. A., & ElSayed, M. E. H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114322 · Cited by 67
Volak, L. P., Duevel, H. M., Humphreys, S. C., Nettleton, D. O., Phipps, C. J., Pike, A., Rynn, C., Scott‐Stevens, P., Zhang, D., & Zientek, M. A. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.001154 · Cited by 68
Dasari, V., McNeil, L. K., Beckett, K. J., Solomon, M., Ambalathingal, G. R., Thuy, T. L., Panikkar, A., Smith, C., Steinbuck, M. P., Jakubowski, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39770-1 · Cited by 74
Bonvin, D., Bastiaansen, J., Stuber, M., Hofmann, H., & Ebersold, M. M. (2017) · Dalton Transactions · doi:10.1039/c7dt02139a · Cited by 64
Li, Z., He, Y., Deng, L., Zhang, Z., & Lin, Y. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb02061f · Cited by 62
Nanomaterial-Based Drug Delivery System Targeting Lymph Nodes
Cheng, Z., Que, H., Chen, L., Sun, Q., & Wei, X. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071372 · Cited by 66
Backlund, C. M., Holden, R. L., Moynihan, K. D., Garafola, D., Farquhar, C., Mehta, N. K., Maiorino, L., Pham, S., Iorgulescu, J. B., Reardon, D. A., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204078119 · Cited by 61
Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system
Lee, J. B., Zgair, A., Malec, J., Kim, T., Kim, M. G., Ali, J., Qin, C., Feng, W., Chiang, M., Gao, X., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.022 · Cited by 63
Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport
Elz, A. S., Trevaskis, N. L., Porter, C. J. H., Bowen, J. M., & Prestidge, C. A. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.003 · Cited by 64
Self-citationTeixeira, M. I., Lopes, C. M., Amaral, M. H., & Costa, P. C. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.09.027 · Cited by 64
Amyloid-β-targeting immunotherapies for Alzheimer's disease
Jin, Y., Du, Q., Song, M., Kang, R., Zhou, J., Zhang, H., & Ding, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.09.012 · Cited by 65
Kumar, S., Narayan, R., Ahammed, V., Nayak, Y., Naha, A., & Nayak, U. Y. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.12.014 · Cited by 57
Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Imaging
Hu, H., Hema, M., Gu, Y., Zhang, Y., Yu, X., & Steinmetz, N. F. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b03956 · Cited by 59
Monoclonal antibodies for severe asthma: Pharmacokinetic profiles
Matera, M. G., Calzetta, L., Rogliani, P., & Cazzola, M. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.05.005 · Cited by 62
Lipid-Based Vectors for Therapeutic mRNA-Based Anti-Cancer Vaccines
Guevara, M. L., Persano, S., & Persano, F. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190619150221 · Cited by 64
Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine
Perche, F., Clemençon, R., Schulze, K., Ebensen, T., Guzmán, C. A., & Pichon, C. (2019) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2019.07.014 · Cited by 55
TPGS Decorated Liposomes as Multifunctional Nano-Delivery Systems
Farooq, M. A., & Trevaskis, N. L. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03424-6 · Cited by 64
Self-citationmRNA vaccine designs for optimal adjuvanticity and delivery
Mochida, Y., & Uchida, S. (2024) · RNA Biology · doi:10.1080/15476286.2024.2333123 · Cited by 63
Sharma, S., Singh, J., Afzal, M., Kaur, R., Imam, S. S., Alruwaili, N. K., Alharbi, K. S., Alotaibi, N. H., Alshammari, M. S., Kazmi, I. A., et al. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101674 · Cited by 58
Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles
Han, S., Mei, L., Quach, T., Porter, C. J. H., & Trevaskis, N. L. (2021) · Pharmaceutical Research · doi:10.1007/s11095-021-03093-x · Cited by 55
Self-citationNanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa
Tang, J., Cai, L., Xu, C., Sun, S., Liu, Y., Rosenecker, J., & Guan, S. (2022) · Nanomaterials · doi:10.3390/nano12020226 · Cited by 60
Duro‐Castaño, A., Nebot, V. J., Niño‐Pariente, A., Armiñán, A., Arroyo‐Crespo, J. J., Paul, A., Feiner‐Gracia, N., Albertazzi, L., & Vicent, M. J. (2017) · Advanced Materials · doi:10.1002/adma.201702888 · Cited by 58
Zeng, F., Wang, D., Tian, Y. F., Wang, M., Liu, R., Xia, Z., & Huang, Y. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.02.030 · Cited by 58
The lymphatic vasculature: An active and dynamic player in cancer progression
Rezzola, S., Sigmund, E. C., Halin, C., & Ronca, R. (2021) · Medicinal Research Reviews · doi:10.1002/med.21855 · Cited by 59
Tang, Y., Liu, B., Zhang, Y., Liu, Y., Huang, Y., & Fan, W. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115304 · Cited by 61
Lin, Z., Xi, L. F., Chen, S., Tao, J., Wang, Y., Chen, X., Li, P., Wang, Z., & Zheng, Y. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.008 · Cited by 55
STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation
Zhang, B., Wu, J., Li, W., Hu, H., Zhao, L., He, P., Zhao, Y., & Li, Y. (2022) · Nano Research · doi:10.1007/s12274-022-4282-x · Cited by 55
Permana, A. D., Nainu, F., Moffatt, K., Larrañeta, E., & Donnelly, R. F. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1690 · Cited by 52
Resveratrol Nanoparticles: A Promising Therapeutic Advancement over Native Resveratrol
Chung, I., Subramanian, U., Thirupathi, P., Venkidasamy, B., Samynathan, R., Gangadhar, B. H., Rajakumar, G., & Thiruvengadam, M. (2020) · Processes · doi:10.3390/pr8040458 · Cited by 56
Chaturvedi, S., Garg, A., & Verma, A. K. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101899 · Cited by 53
Lee, S. N., Jin, S. M., Shin, H. S., & Lim, Y. T. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00337 · Cited by 52
Lymphatic immunomodulation using engineered drug delivery systems for cancer immunotherapy
Manspeaker, M. P., & Thomas, S. N. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.004 · Cited by 52
Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy
Tong, Q., Li, K., Huang, F., Dai, Y., Zhang, T., Muaibati, M., Abasi, A., & Huang, X. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100845 · Cited by 62
Subcutaneous delivery of biotherapeutics: challenges at the injection site
Sequeira, J. A. D., Paiva‐Santos, A. C., Serra, J. P., Estevens, C., Seiça, R. M. F., Veiga, F., & Ribeiro, A. J. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1568408 · Cited by 54
Zhang, L., Peng, H., Zhang, W., Li, Y., Liu, L., & Leng, T. (2020) · Theranostics · doi:10.7150/thno.46761 · Cited by 50
Bala, V., Rao, S., Bateman, E. H., Keefe, D. M. K., Wang, S., & Prestidge, C. A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00591 · Cited by 51
Kraft, J. C., McConnachie, L. A., Koehn, J., Kinman, L., Sun, J., Collier, A. C., Collins, C. J., Shen, D. D., & Ho, R. J. Y. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.003 · Cited by 54
A lymph node–targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2
Steinbuck, M. P., Seenappa, L. M., Jakubowski, A., McNeil, L. K., Haqq, C. M., & DeMuth, P. C. (2021) · Science Advances · doi:10.1126/sciadv.abe5819 · Cited by 50
Ganesh, A. N., Heusser, C., Garad, S., & Sánchez-Félix, M. V. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100079 · Cited by 50
Nanoparticle-based approaches to target the lymphatic system for antitumor treatment
Peng, X., Wang, J., Zhou, F., Liu, Q., & Zhang, Z. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03842-6 · Cited by 48
Singh, Y., Srinivas, A., Gangwar, M., Meher, J. G., Misra‐Bhattacharya, S., & Chourasia, M. K. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00206 · Cited by 48
Yu, G., Jung, H., Kang, Y. Y., & Mok, H. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.003 · Cited by 50
Computational modelling of fluid and solute transport in the brain
Martinac, A. D., & Bilston, L. E. (2019) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-019-01253-y · Cited by 51
An Injectable Nanocomposite Hydrogel Improves Tumor Penetration and Cancer Treatment Efficacy
Luo, F., Xu, W., Zhang, J., Liu, R., Huang, Y., Xiao, C., & Du, J. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.05.042 · Cited by 51
Elastic Nanovaccine Enhances Dendritic Cell‐Mediated Tumor Immunotherapy
Li, Q., Teng, Z., Tao, J., Shi, W., Yang, G., Zhang, Y., Su, X., Chen, L., Xiu, W., Yuwen, L., et al. (2022) · Small · doi:10.1002/smll.202201108 · Cited by 52
Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative
Alrushaid, S., Sayre, C. L., Yáñez, J. A., Forrest, M. L., Senadheera, S. N., Burczynski, F. J., Löbenberg, R., & Davies, N. M. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9030035 · Cited by 49
Lymphatic changes in cancer and drug delivery to the lymphatics in solid tumors
Cote, B., Rao, D. A., Alany, R. G., Kwon, G. S., & Alani, A. W. G. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.08.009 · Cited by 49
Birmingham, K. G., O’Melia, M. J., Bordy, S., Aguilar, D. R., El-Reyas, B., Lesinski, G. B., & Thomas, S. N. (2020) · iScience · doi:10.1016/j.isci.2020.101751 · Cited by 52
Lee, G., Han, S., Inocencio, I., Cao, E., Hong, J., Phillips, A. R. J., Windsor, J. A., Porter, C. J. H., & Trevaskis, N. L. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00855 · Cited by 46
Self-citationThe Lymph Node Reservoir: Physiology, HIV Infection, and Antiretroviral Therapy
Scholz, E. M. B., & Kashuba, A. D. M. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2186 · Cited by 59
Impact of nanoparticle properties on immune cell interactions in the lymph node
Farooq, M. A., Johnston, A. P. R., & Trevaskis, N. L. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.12.039 · Cited by 52
Self-citationYou, Q., Wu, G., Li, H., Liu, J., Cao, F., Ding, L., Liang, F., Zhou, B., Ma, L., Zhu, L., et al. (2025) · Nature Nanotechnology · doi:10.1038/s41565-025-01952-x · Cited by 56
Jucker, B. M., Alsaid, H., Rambo, M. V., Lenhard, S. C., Hoang, B. Q., Xie, F., Groseclose, M. R., Castellino, S., Damian, V., Bowers, G. D., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.10.017 · Cited by 46
Smart combination of aluminum hydroxide and MF59 to induce strong cellular immune responses
Chen, Z., Hao, X., Wang, H., Zhong, X., Chen, X., Zhao, Y., Zhang, Y., Du, G., & Sun, X. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.07.032 · Cited by 45
A Mn Al double adjuvant nanovaccine to induce strong humoral and cellular immune responses
Qiao, N., Wang, H., Xu, Y., Chang, Y., Xie, M., Bai, S., He, C., Qin, M., Zhong, X., Jiang, M., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.036 · Cited by 48
Xie, H., Zhu, H. H., Zhou, K., Wan, J., Zhang, L., Yang, Z., Zhou, L., Chen, X., Xu, X., Zheng, S., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.043 · Cited by 46
Rajput, A., Pingale, P., Telange, D. R., Chalikwar, S. S., & Borse, V. B. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102934 · Cited by 46
Cracking the intestinal lymphatic system window utilizing oral delivery vehicles for precise therapy
Miao, Y., Xu, T., Gong, Y., Chen, A., Zou, L., Jiang, T., & Shi, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01991-3 · Cited by 47
Drug–Lipid Conjugates for Enhanced Oral Drug Delivery
Date, T., Paul, K., Singh, N., & Jain, S. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-018-1272-0 · Cited by 43
Prasad, C., Bhatia, E., & Banerjee, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-65468-1 · Cited by 44
Gastrointestinal lipolysis and trans-epithelial transport of SMEDDS via oral route
Xia, F., Chen, Z., Zhu, Q., Qi, J., Dong, X., Zhao, W., Wu, W., & Lü, Y. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.006 · Cited by 43
Drainage of senescent astrocytes from brain via meningeal lymphatic routes
Li, Q., Chen, Y., Feng, W., Cai, J., Gao, J., Ge, F., Zhou, T., Wang, Z., Ding, F., Marshall, C., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.04.005 · Cited by 47
Bacterial Lymphatic Metastasis in Infection and Immunity
Siggins, M. K., & Sriskandan, S. (2021) · Cells · doi:10.3390/cells11010033 · Cited by 51
Timur, S. S., Yöyen-Ermiş, D., Esendağlı, G., Yonat, S., Horzum, U., Esendağlı, G., & Gürsoy, R. N. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.01.017 · Cited by 46
Chang, H., Zou, Z., Wang, Q., Li, J., Jin, H., Yin, Q.-X., & Xing, D. (2019) · Advanced Science · doi:10.1002/advs.201900069 · Cited by 42
Yeast microcapsule-mediated oral delivery of IL-1β shRNA for post-traumatic osteoarthritis therapy
Zhang, L., Peng, H., Feng, M., Zhang, W., & Li, Y. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.11.006 · Cited by 46
Lymphatic Vasculature: An Emerging Therapeutic Target and Drug Delivery Route
Xu, W., Harris, N. R., & Caron, K. M. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-051419-114417 · Cited by 43
Targeting immune cells within lymph nodes
Porter, C. J. H., & Trevaskis, N. L. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0663-z · Cited by 41
Self-citationPenetration and translocation of functional inorganic nanomaterials into biological barriers
Cong, Y., Baimanov, D., Zhou, Y., Chen, C., & Wang, L. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114615 · Cited by 40
Recent progress in cancer vaccines and nanovaccines
Poudel, K., Vithiananthan, T., Kim, J. O., & Tsao, H. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122856 · Cited by 43
Han, S., Hu, L., Gracia, Quach, T., Simpson, J. S., Edwards, G. A., Trevaskis, N. L., & Porter, C. J. H. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00195 · Cited by 42
Self-citationRen, T., Zheng, X., Bai, R., Yang, Y., & Jian, L. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120583 · Cited by 40
Metadata
- Authors
- Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H.
- Affiliations
- Monash University (AU)
- Corresponding author
- Porter, Christopher J. H.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-10-16
- Volume
- 14
- Issue
- 11
- Pages
- 781-803
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2204416339
- Cited by
- 654
- References
- 287
- Citations by year
- 2026: 43 · 2025: 59 · 2024: 66 · 2023: 71 · 2022: 76 · 2021: 95 · 2020: 81 · 2019: 61 · 2018: 42 · 2017: 38 · 2016: 20 · 2015: 1
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- green
- research.monash.edu
- Licence
- other-oa
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Keywords
- lymph node targeting, lymphatic drug delivery, lymphatic system, nanotechnology, lipid conjugates, prophylactic vaccination, therapeutic vaccination, tolerance induction, metastasis, lymph nodes, obesity, atherosclerosis, bioavailability, drug development
- MeSH terms
- Animals, Biological Transport, Humans, Lymphatic System, Neoplasms, Prodrugs, Drug Delivery Systems, Lymphatic Vessels, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.